Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0A4RF
|
|||
Former ID |
DIB018034
|
|||
Drug Name |
PMID17935984C1
|
|||
Synonyms |
CHEBI:45030; 1you; AC1LCVYP; GTPL6526; BDBM50224854; DB08388
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Pain [ICD-11: MG30-MG3Z] | Clinical trial | [1], [2] | |
Structure |
Download2D MOL
|
|||
Formula |
C20H19FN2O6
|
|||
Canonical SMILES |
CCOCCC1(C(=O)NC(=O)NC1=O)OC2=CC=C(C=C2)OC3=CC=C(C=C3)F
|
|||
InChI |
1S/C20H19FN2O6/c1-2-27-12-11-20(17(24)22-19(26)23-18(20)25)29-16-9-7-15(8-10-16)28-14-5-3-13(21)4-6-14/h3-10H,2,11-12H2,1H3,(H2,22,23,24,25,26)
|
|||
InChIKey |
XRSYNYGEEYTXJV-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:45030
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Matrix metalloproteinase-13 (MMP-13) | Target Info | Inhibitor | [1] |
NetPath Pathway | IL1 Signaling Pathway | |||
Panther Pathway | Alzheimer disease-presenilin pathway | |||
Plasminogen activating cascade | ||||
Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | |||
Reactome | Collagen degradation | |||
Degradation of the extracellular matrix | ||||
Activation of Matrix Metalloproteinases | ||||
Assembly of collagen fibrils and other multimeric structures | ||||
WikiPathways | Endochondral Ossification | |||
Activation of Matrix Metalloproteinases | ||||
Oncostatin M Signaling Pathway | ||||
AGE/RAGE pathway | ||||
Matrix Metalloproteinases |
References | Top | |||
---|---|---|---|---|
REF 1 | Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13. Bioorg Med Chem Lett. 2007 Dec 1;17(23):6529-34. | |||
REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6526). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.